FidoCure
AI-Enabled Personalized Therapeutics for Canine Cancer
FidoCure is an AI-enabled personalized cancer care service for dogs that uses genomic testing and tumor profiling to identify cancer-driving mutations. Based on these insights, the platform recommends targeted therapeutic options tailored to each individual dog. Developed by One Health Company, FidoCure works through licensed veterinarians and has built the largest proprietary canine cancer dataset in the world.
FidoCure performs genomic testing and tumor profiling on a dog's cancer to identify mutations, then recommends personalized targeted therapy options to the treating veterinarian.
Dog owners and veterinarians dealing with canine cancer diagnoses
Background.
- Status
- launched
- Business model
- unknown
- Company
- One Health Company
- Launched
- 2018
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.